The Discounted Cash Flow (DCF) valuation of PTC Therapeutics Inc (PTCT) is (280.20) USD. With the latest stock price at 47.36 USD, the upside of PTC Therapeutics Inc based on DCF is -691.6%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.4% - 9.2% | 7.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (707.05) - (185.24) | (280.20) |
| Upside | -1592.9% - -491.1% | -691.6% |